Company attributes
Location
No article content yet.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
E3X Bio is a company focused on developing inhibitors and activators of E3 Ubiquitin (Ub) ligases for drug discovery and development for oncology, inflammation, infectious disease and neurodegeneration.